Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MustGrow BiologicsMGROF +11.29%24 Net Cash per Share is $-0.02 as of Mar. 2026. GuruFocus rates MGROF with a GF Score™ of 24/100. The stock has 3 warning signs investors should review. Among 30 Agriculture companies, MustGrow Biologics ranks worse than 3333330% on this metric.
The historical rank and industry rank for MustGrow Biologics's Net Cash per Share or its related term are showing as below:
During the past 10 years, the highest Price-to-Net-Cash Ratio of MustGrow Biologics was 66.00. The lowest was 6.20. And the median was 22.27.
MGROF's Price-to-Net-Cash is not ranked *
in the Agriculture industry.
Industry Median: 10.52 * Ranked among companies with meaningful Price-to-Net-Cash only.
MustGrow Biologics (OTCPK:MGROF) Net Cash per Share Explanation
Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.
You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.
MustGrow Biologics Net Cash per Share Related Terms
MustGrow Biologics Net Cash per Share Historical Data
* Premium members only.
The historical data trend for MustGrow Biologics's Net Cash per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MGROF vs CTVA, CF, MOS: Net Cash per Share Comparison
For the Agricultural Inputs subindustry, MustGrow Biologics's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MustGrow Biologics Price-to-Net-Cash vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, MustGrow Biologics's Price-to-Net-Cash distribution charts can be found below:
* The bar in red indicates where MustGrow Biologics's Price-to-Net-Cash falls into.
In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.
MustGrow Biologics's Net Cash per Share for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MustGrow Biologics (MGROF) has a Net Cash per Share of $-0.02 as of Mar. 2026. Net cash per share equals the per-share value of cash and equivalents less total liabilities and minority interest. View historical data on MustGrow Biologics and its competitors. Over the past decade, MustGrow Biologics' Net Cash per Share has ranged from 6.20 to 66.00. According to the industry distribution chart, MustGrow Biologics ranks #999999 out of 30 companies in the Agriculture industry.
Is MustGrow Biologics' Net Cash per Share too high?
MustGrow Biologics' current Net Cash per Share is $-0.02. Over the past 10 years, this metric has ranged from a low of 6.20 to a high of 66.00. Based on the distribution chart, MustGrow Biologics ranks #999999 out of 30 companies in the Agriculture industry, which is in the bottom quartile relative to peers. Overall, MustGrow Biologics has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does MustGrow Biologics' Net Cash per Share compare to CTVA and CF?
According to the Agriculture industry distribution chart, MustGrow Biologics ranks #999999 out of 30 companies for Net Cash per Share. This places MustGrow Biologics in the lower half of its industry. The industry median Net Cash per Share is 10.52. Historically, MustGrow Biologics' own Net Cash per Share has ranged from 6.20 to 66.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Cash per Share for an Agriculture company?
The median Net Cash per Share among Agriculture companies is 10.52, based on 30 companies in the industry. Companies in the top quartile (top 25%) have a Net Cash per Share significantly above this median, while those in the bottom quartile fall well below. However, Net Cash per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Cash per Share mean?
A high Net Cash per Share can signal that a stock is expensive relative to its fundamentals. Net cash per share equals the per-share value of cash and equivalents less total liabilities and minority interest. View historical data on MustGrow Biologics and its competitors. For the Agriculture industry, the median Net Cash per Share is 10.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MustGrow Biologics's current Net Cash per Share is $-0.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MustGrow Biologics stock overvalued right now?
MustGrow Biologics (MGROF) has a current Net Cash per Share of $-0.02. The current Net Cash per Share is $-0.02. MustGrow Biologics' overall GF Score™ is 24/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Cash per Share calculated?
Net Cash per Share is calculated from a company's financial statements. For MustGrow Biologics (MGROF), the current Net Cash per Share is $-0.02 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
MustGrow Biologics Corp is a fully integrated provider of biological and regenerative agriculture solutions designed to support sustainable farming. The Company's proprietary and third-party product lines offer eco-friendly alternatives to restricted or banned synthetic chemicals and fertilizers. It offers a portfolio of third-party crop nutrition solutions, including micronutrients, nitrogen stabilizers, biostimulants, and foliar products. These products are synergistically distributed alongside MustGrow's wholly owned proprietary products and technologies that are derived from mustard and developed into organic biocontrol and biofertility products to help replace banned or restricted synthetic chemicals and fertilizers.
24GF Score
Get the complete analysis for MGROF
Net Cash per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MGROF has been successfully added to your 
